Načítá se...
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
INTRODUCTION: Direct current cardioversion (DCCV) is considered as the most effective treatment for atrial fibrillation (AF). AF is associated with an increased risk of thromboembolism, and DCCV may increase this risk. The current recommendation is, therefore, to anticoagulate for at least 3 weeks b...
Uloženo v:
| Vydáno v: | Cardiol Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5125109/ https://ncbi.nlm.nih.gov/pubmed/27457612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40119-016-0067-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|